L
LensGen, Inc.
Ophthalmic medical device company that has developed a biomimetic, Curvature Changing Fluid-Optic Intraocular Lens designed for the treatment of cataracts and presbyopia
About LensGen, Inc.
LensGen is an ophthalmic medical device company specializing in the development of innovative intraocular lenses (IOLs) designed to mimic the natural human lens. The company's core product is a curvature-changing, fluid optic intraocular lens that aims to rejuvenate youthful vision for individuals affected by cataracts and presbyopia. This advanced lens works with the eye's natural accommodation mechanism to provide a continuous range of vision from distance to near, eliminating the need for reading glasses.
LensGen operates in the global ophthalmic market, targeting patients undergoing cataract surgery, which is performed in over 28 million procedures annually worldwide. The company's business model revolves around the development, clinical testing, and eventual commercialization of its proprietary lens technology. Revenue generation is expected through the sale of these advanced intraocular lenses to eye care professionals and surgical centers once regulatory approvals are obtained.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Aug 2020 | $10M | $55M | HOYA Electronics | — |
| SERIES AOther financing | Jul 2018 | $11M | $44M | HOYA Electronics | — |
Growth signals
Latest recorded traffic for LensGen, Inc. is 1.6K monthly website visits, up 23.1% over the last three months. LensGen, Inc.'s team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
LensGen, Inc. in the Irvine ecosystem
The LensGen, Inc. office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Amir Banifatemi
K5 Ventures
Rahul Harkawat
MedTech Innovator
Series A2 investors entered at this stage
HOYA Electronics
Relativity Healthcare Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about LensGen, Inc. on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LensGen, Inc.’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








